1. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts
2. Clinical Physiology. Textbook for medical colleges and universities in the 2l century;He,2001
3. CDK4/6 inhibitors combined with endocrine therapy for advanced breast cancer;Qian;Journal of Practical Oncology,2021
4. Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
5. Palbociclib in Combination with Letrozole Versus Letrozole alone as First-Line Treatment of Oestrogen Receptor Positive, HER2-Negative;Wang;Advanced Breast Cancer Significantly Improve Progression-Free Survivial,2015